Review
World J Hepatol
8(22):915-923.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.915
Abstract (1018)
|
Core Tip (1039)
|
Full Article (HTML) (3630)
|
Full Article (PDF)-777K (594)
|
Audio-357K (35)
|
Peer-Review Report-122K (146)
|
Answering Reviewers-64K (186)
|
Received: 02/20/2016
|
Revised: 04/22/2016
|
Accepted: 06/16/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (15)
|
Total Visits (10310)
|
Similar Articles (16)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Cholesterol metabolism in cholestatic liver disease and liver transplantation: From molecular mechanisms to clinical implications
World J Hepatol
8(22):924-932.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.924
Abstract (1171)
|
Core Tip (1184)
|
Full Article (HTML) (10454)
|
Figures (1-4) (1183)
|
Full Article (PDF)-948K (1274)
|
Audio-1310K (26)
|
Peer-Review Report-106K (359)
|
Answering Reviewers-19K (225)
|
Received: 03/31/2016
|
Revised: 06/07/2016
|
Accepted: 07/13/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (55)
|
Total Visits (22388)
|
Similar Articles (472)
|
Timeline of Article Publication (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Antifibrotic effects of ambrisentan, an endothelin-A receptor antagonist, in a non-alcoholic steatohepatitis mouse model
World J Hepatol
8(22):933-941.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.933
Abstract (1101)
|
Core Tip (1101)
|
Full Article (HTML) (4455)
|
Figures (1-2) (221)
|
Tables (1-2) (206)
|
Full Article (PDF)-1246K (681)
|
Audio-442K (32)
|
Peer-Review Report-131K (296)
|
Answering Reviewers-120K (189)
|
Received: 03/02/2016
|
Revised: 04/27/2016
|
Accepted: 07/13/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (10)
|
Total Visits (15552)
|
Similar Articles (15)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
Living donor liver transplantation for high model for end-stage liver disease score: What have we learned?
World J Hepatol
8(22):942-948.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.942
Abstract (1011)
|
Core Tip (1019)
|
Full Article (HTML) (3371)
|
Figures (1-3) (218)
|
Tables (1-1) (213)
|
Full Article (PDF)-814K (494)
|
Audio-757K (21)
|
Peer-Review Report-105K (227)
|
Answering Reviewers-109K (204)
|
Received: 03/15/2016
|
Revised: 05/02/2016
|
Accepted: 07/13/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (4)
|
Total Visits (14185)
|
Similar Articles (34)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
World J Hepatol
8(22):949-956.
Published online Aug 8, 2016.
doi: 10.4254/wjh.v8.i22.949
Abstract (1079)
|
Core Tip (1089)
|
Full Article (HTML) (3612)
|
Tables (1-3) (195)
|
Full Article (PDF)-799K (460)
|
Audio-1969K (21)
|
Peer-Review Report-132K (206)
|
Answering Reviewers-50K (178)
|
Received: 02/23/2016
|
Revised: 06/23/2016
|
Accepted: 07/22/2016
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (5)
|
Total Visits (12765)
|
Similar Articles (9)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open